Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable region OR22-1 (IGLV(IV)/OR22-1)
- Target
- IGLV(IV)/OR22-1
- Molecular classification
- Immunoglobulin variable gene segment, Antibody gene segment, Other
01
Overview
The immunoglobulin lambda variable region OR22-1 (IGLV(IV)/OR22-1) is a gene segment that encodes a variable region of the lambda light chain of human antibodies. Immunoglobulin variable regions are responsible for antigen binding specificity and contribute to antibody diversity through genetic recombination events in developing B cells. The "OR22-1" designation follows standardized nomenclature for antibody variable gene segments but does not denote a specific protein or receptor with therapeutic relevance. This gene segment is part of the immunoglobulin lambda locus on chromosome 22 and is not considered a standalone therapeutic target, receptor, enzyme, or transporter[1][2][3].
- Other names
- Immunoglobulin lambda variable/OR22-1IGLV(IV)/OR22-1IGLVIVOR22-1
02
Mechanism of action
Not applicable (gene segment, not a therapeutic target)
03
Biological functions
Antigen recognitionImmune responseGeneration of antibody diversity
04
Disease associations
Other
Beyond the preview
Go deeper on Immunoglobulin lambda variable region OR22-1 (IGLV(IV)/OR22-1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunoglobulin lambda variable region OR22-1 (IGLV(IV)/OR22-1).